Skip to main content

BioNTech SE (BNTX)

NASDAQ: BNTX · IEX Real-Time Price · USD
293.51
-1.41 (-0.48%)
After-hours:Oct 25, 2021 7:59 PM EDT
294.92
16.58 (5.96%)
At close: Oct 25, 4:00 PM

Income Statement (Annual)

Financials in millions EUR. Fiscal year is January - December.
Year2020201920182017
Revenue
482.33108.59127.5861.6
Revenue Growth
344.17%-14.88%107.11%-
Cost of Revenue
59.3317.3613.699.32
Gross Profit
422.9991.23113.8952.28
Selling, General & Admin
108.5648.2729.3830.12
Research & Development
645.03226.47143.0485.5
Other Operating Expenses
-248.18-1.99-4.68-2.06
Operating Expenses
505.41272.75167.74113.56
Operating Income
-82.42-181.52-53.85-61.28
Interest Expense / Income
64.952.041.7726.68
Other Expense / Income
-1.56-4.24-8.2-2.35
Pretax Income
-145.8-179.32-47.42-85.61
Income Tax
-161-0.270.60.05
Net Income
15.2-179.06-48.02-85.65
Net Income Common
15.2-179.06-48.02-85.65
Shares Outstanding (Basic)
227226226-
EPS (Basic)
0.06-0.85-0.25-0.51
EPS (Diluted)
0.06-0.85-0.25-0.51
Free Cash Flow Per Share
-0.43-1.19-0.55-
Gross Margin
87.70%84.01%89.27%84.87%
Operating Margin
-17.09%-167.16%-42.21%-99.48%
Profit Margin
3.15%-164.89%-37.64%-139.05%
Free Cash Flow Margin
-20.25%-248.27%-98.24%-116.38%
Effective Tax Rate
110.42%0.15%-1.27%-0.05%
EBITDA
-42.11-143.38-23.67-48.4
EBITDA Margin
-8.73%-132.04%-18.55%-78.57%
EBIT
-80.85-177.28-45.65-58.93
EBIT Margin
-16.76%-163.26%-35.78%-95.66%
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).